Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

BACKGROUND: Patients with ankylosing spondylitis (AS) are at increased risk of depression. This increased risk has been hypothesized to be solely secondary due to AS-related symptoms, or additionally due to a common inflammatory pathway. From a clinical perspective, it is important to know whether t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Arthritis Res Ther
Hlavní autoři: Webers, Casper, Stolwijk, Carmen, Schiepers, Olga, Schoonbrood, Thea, van Tubergen, Astrid, Landewé, Robert, van der Heijde, Désirée, Boonen, Annelies
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523309/
https://ncbi.nlm.nih.gov/pubmed/32993799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02305-w
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky